GDS Ramsay Generale de Sante

RAMSAY SANTE : Availability of the Universal Registration Document 2024

RAMSAY SANTE : Availability of the Universal Registration Document 2024

PRESS RELEASE

                Paris, 30th October 2024

AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2024

Ramsay Générale de Santé's 2024 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) in ESEF format (European Single Electronic Format) on Wednesday 30 October 2024, under number D.24-0783. It is available to the public under the conditions provided for by the regulations in force and can be consulted on the Ramsay Santé website: .

The Universal Registration Document is also available on the AMF website -france.org)

The Universal Registration Document, prepared for the financial year ended 30 June 2024, includes, inter alia:

  • the annual financial report and the integrated report,
  • the Board of Directors' report on corporate governance,
  • the management report, including the extra-financial performance declaration,
  • the auditors' reports and information on their fees,
  • the description of the share buyback program.



About Ramsay Santé

Ramsay Santé is the leader in private hospitalisation and primary care in Europe. The Group has 38,000 employees and works with nearly 10 000 practitioners to treat more than 12,6 million patients per year in its 488 facilities and 5 countries: France, Sweden, Norway, Denmark and Italy. Ramsay Santé offers almost all medical and surgical specialities in three domains: Medicine, Surgery, Obstetrics (MSO), Follow-up Care and Rehabilitation (FCR) and Mental Health.

Legally, Ramsay Santé is a mission-driven company committed to constantly improving the health of all patients through innovation. Wherever it operates, the Group contributes to public health service missions and the healthcare network. Through its actions and the constant dedication of its teams, Ramsay Santé is committed to ensuring the entire patient care journey, from prevention to follow-up care.

Every year, the group invests over 200 million euros in innovation to support the evolution and diversity of care pathways, in medical, hospital, digital, and administrative aspects. Through this commitment, our Group enhances access to care for all, commits to provides best-in-class healthcare, systematically engages in dialogue with stakeholders and strives to protect the planet to improve health.

Facebook:  

Instagram:  

Twitter:  

LinkedIn:  

YouTube:  

Code ISIN and Euronext Paris: FR0000044471 

Website:   

Investor / Analyst Relations        Press Relations

Clément Lafaix        Brigitte Cachon

Tél. 52        Tél. 11

        

Attachment



EN
30/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ramsay Generale de Sante

 PRESS RELEASE

Ramsay Sante : Provisional annual Results at the end of June 2025

Ramsay Sante : Provisional annual Results at the end of June 2025         PRESS RELEASE                 Paris, 27th August 2025 Provisional annual results at the end of June 2025Revenue growth of 4.7% and Group EBITDA up 1.7% despite reduction in public funding; secured long term financing framework Activity growth and cost control mitigate low French tariffs Group revenue increased by 4.7% to €5.2bn supported by activity volume growth and former Cosem primary care centres acquired in June 2024. Revenue growth of 2.7% on a like-for-like basis.Group EBITDA reported for the year ended Jun...

 PRESS RELEASE

RAMSAY SANTE : résultats annuels provisoires à fin juin 2025

RAMSAY SANTE : résultats annuels provisoires à fin juin 2025         COMMUNIQUÉ DE PRESSE                Paris, le 27 août 2025 Résultats annuels provisoires à fin juin 2025Croissance du chiffre d'affaires de 4,7 % et EBITDA en hausse de 1,7 % malgré une baisse du financement public ; structure de financement long terme assurée Croissance d’activité et contrôle des coûts viennent atténuer des tarifs insuffisants en France Le chiffre d'affaires du groupe a augmenté de 4,7% à 5,2 milliards d'euros, soutenu par la hausse du volume d'activité et l'acquisition en juin 2024 des centres de soin...

 PRESS RELEASE

Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of ...

Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of the Board PRESS RELEASEParis, 26th June 2025 Ramsay Générale de Santé Board of Directors appoints Natalie Davis as Chairman of the Board At its meeting today, the Board of Directors announced the appointment of Natalie Davis as Chairman of the Board of Directors. She succeeds Craig McNally, who is stepping down from this position, which he has held since 2017. "On behalf of the entire Ramsay Santé Group team, I would like to offer Craig McNally our sincerest thanks for his eight years of exemplary commitment as Chair...

 PRESS RELEASE

RAMSAY GENERALE DE SANTE : nomination de Natalie Davis Présidente du C...

RAMSAY GENERALE DE SANTE : nomination de Natalie Davis Présidente du Conseil d'Administration 26 juin 2025 COMMUNIQUÉ DE PRESSEParis, le 26 juin 2025 Le Conseil d’Administration de Ramsay Générale de Santé nomme Natalie Davis Présidente du Conseil Le Conseil d’administration réuni ce jour, annonce la nomination de Natalie Davis au poste de Présidente du Conseil d’Administration. Elle succède à Craig McNally qui quitte cette fonction qu’il occupait depuis 2017. «Au nom de l’ensemble des équipes du groupe Ramsay Santé, je tiens à adresser, à Craig McNally nos remerciements les plus sincè...

 PRESS RELEASE

RAMSAY SANTE : Interim results at the end of March 2025

RAMSAY SANTE : Interim results at the end of March 2025         PRESS RELEASE                Paris, 14th May 2025 Interim results at the end of March 2025 Activity growth and cost control compensate pricing headwinds Unaudited group revenue for the nine months period ending 31 March 2025 increased by 5.1% to 3.9bn€ supported by activity volume growth and Cosem primary care centres acquired in June 2024. Revenue growth of 3.2% on a like-for-like basis.Unaudited group EBITDA for the nine months period ending 31 March 2025 was almost stable at 441m€, -0.8% or -3.6m€ compared to the prior ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch